1396311-82-2Relevant articles and documents
NEW BRAF INHIBITORS AS PARADOX BREAKERS
-
, (2021/06/22)
The invention provides a novel compound having the general formula (I) (I) wherein R1-R3 and X are as defined in the description and in the claims. The compound of formula (I) can be used as a medicament.
HETEROCYCLIC SULFONAMIDES AS RAF INHIBITORS
-
Page/Page column 89-90, (2012/09/21)
Compounds of Formula (I) are useful for inhibition of Raf kinases. Methods of using compounds of Formula (I), stereoisomers, tautomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.